Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05974644 · ClinicalTrials.gov registry record
Southeastern ATTR Amyloidosis Consortium: SEATTRAC Family Registry
A clinical trial, sponsored by Virginia Commonwealth University.
- Not yet
- Registry status
- 1,000
- Enrollment target
NCT05974644 is a clinical trial that has not yet begun recruiting, run by Virginia Commonwealth University. The registered enrollment target is 1,000 participants.
The verdict
NCT05974644 has not yet begun recruiting, sponsored by Virginia Commonwealth University.
- NOT YET RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
The study design is a prospective registry including asymptomatic and symptomatic patients who carry a pathogenic TTR mutation. The study will enroll patients who meet the inclusion criteria and none of the exclusion criteria until 1000 patients are enrolled, at which point in time the study investigators will evaluate whether further patient accrual is meaningful.
Interventions
- OTHER Registry
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2026-07 |
| Est. Completion | 2030-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05974644
The ClinicalTrials.gov registry entry for NCT05974644 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Registry is the first listed.
NCT05974644 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05974644 about?
NCT05974644 is a clinical study titled "Southeastern ATTR Amyloidosis Consortium: SEATTRAC Family Registry". The study design is a prospective registry including asymptomatic and symptomatic patients who carry a pathogenic TTR mutation. The study will enroll patients who meet the inclusion criteria and none of the exclusion criteria until 1000 patients are enrolled, at which point in time the study investi...
What is the current status of trial NCT05974644?
This trial is currently not yet recruiting. The enrollment target is 1,000 participants. The study started on 2026-07. Estimated completion is 2030-12-01.
What interventions are being tested in trial NCT05974644?
The interventions under investigation include: Registry (OTHER).
Who is sponsoring clinical trial NCT05974644?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.